NobleBlocks

Brocher Foundation

funderGeneva, Switzerland

Research output, citation impact, and the most-cited recent papers from Brocher Foundation (Switzerland). Aggregated across the NobleBlocks index of 300M+ scholarly works.

Total works
7
Citations
442
h-index
7
i10-index
6
Also known as
Brocher FoundationFondation Brocher

Top-cited papers from Brocher Foundation

Who’s to blame? Accounts of genetic responsibility and blame among Ashkenazi Jewish women at risk of BRCA breast cancer
Jessica Mozersky
2012· Sociology of Health & Illness18doi:10.1111/j.1467-9566.2011.01427.x

Genetic knowledge of disease risk may induce a sense of genetic responsibility whereby those who are at risk feel an obligation to take certain actions not only in relation to their own personal health but also to their family, their children and many other aspects of their life. This article examines genetic responsibility among Ashkenazi Jewish women at increased risk of BRCA genetic breast cancer. It demonstrates the ways in which accounts of blame help to mitigate or allocate genetic responsibility and in particular focuses on the temporal nature of women's accounts. Women locate responsibility or blame for genetic disease in the collective reproductive history of Ashkenazi Jews, currently among specific groups of Ashkenazi Jews, and this knowledge can have potential future reproductive consequences. A contradiction may arise between a pre-existing sense of responsibility to produce future generations of Jews with that of producing future breast cancer free children. The research is based on in-depth qualitative interviews with 14 high-risk Ashkenazi Jewish women in London, England.

What are the implications of changing treatment delivery models for patients with inflammatory bowel disease
Antonina Mikocka‐Walus, Jane M. Andrews, Roland von Känel, Gabriele Moser
2012· European Journal of Gastroenterology & Hepatology17doi:10.1097/meg.0b013e32835c07b4

An integrated model of care has been used effectively to manage chronic diseases; however, there is limited, yet encouraging evidence on its introduction in the management of inflammatory bowel disease (IBD), a chronic gastrointestinal condition. Here, the rationale for and implications of introducing an integrated model of care for patients with IBD are discussed, with a particular focus on psychology input, patient-centred care, efficiency as perceived by patients and doctors, financial implications and the possible means of model introduction. This is a discussion paper on the integrated model of care for IBD against a background of what has been learned from an integrated model of care established in other chronic conditions. Although limited, the emerging data on an integrated model of care in IBD are encouraging with respect to patient outcomes and savings in healthcare costs. In other conditions, the model has been well received by both patients and practitioners, although the loss of autonomy by doctors is listed among its drawbacks. The cost-effectiveness data are now sufficiently convincing to recommend the model's acceptance in principle. The model should be promoted at the policy level rather than by individual practitioners to facilitate equal access for patients with IBD on a larger scale than currently.

An improved model of care for inflammatory bowel disease (IBD)
Antonina Mikocka‐Walus, Jane M. Andrews, Roland von Känel, Gabriele Moser
2012· Journal of Crohn s and Colitis8doi:10.1016/j.crohns.2012.08.004

Recommendations from the 3rd round of the Report of\nthe results for the national clinical audit of adult inflammatory bowel disease (IBD) inpatient care in the UK published earlier this year by UK's Royal College of Physicians and mentioned in the Lancet in March 20121 report improvements in the quality of care (QoC) of patients with IBD since audits began in 2006 but also list improvements yet to be achieved. Importantly, optimising the quality of life\n(QoL) of sufferers was indicated as deserving greater attention as part of the global approach to improved QoC.

Uncertainty and Managing Randomness: The First Documented Cholera Epidemic in Bombay City and Presidency, 1818-1821
Vivek Neelakantan
2023· Paramita Historical Studies Journaldoi:10.15294/paramita.v33i2.45271

Between 1817 and 1821, the Indian subcontinent was devastated by a series of cholera outbreaks that have subsequently been referred to as the beginning of the First Cholera Pandemic. Although the history of the First Cholera Pandemic has received some scholarly attention, historians tend to overlook the local features of the pandemic in favor of the broader colonial context. In this article, the author contends that the official response to the epidemic in Bombay city and presidency (1818-1821) was initially ameliorative, including recruiting native medical assistants to administer treatment. Such a measure was calculated to cultivate a benevolent image of the colonial government among local inhabitants. Despite considerable nosological and etiological disagreements, members of the Bombay Medical Board characterized cholera as a social disease. Unlike cholera epidemics in the latter half of the nineteenth century, the first cholera epidemic in the Bombay presidency did little to exacerbate antagonism towards the colonial government for two reasons. First, the British power in India was still at its formative stage. Second, both in India and England, cholera was associated with the derangement of bodily humors. On the contrary, the epidemic provided a stimulus to intracommunal discord. Antara tahun 1817 dan 1821, anak benua India dilanda serangkaian wabah kolera yang kemudian disebut sebagai awal dari Pandemi Kolera Pertama. Meskipun sejarah Pandemi Kolera Pertama telah mendapat perhatian ilmiah, para sejarawan cenderung mengabaikan ciri-ciri lokal dari pandemi ini dan lebih memilih konteks kolonial yang lebih luas. Dalam artikel ini, penulis berpendapat bahwa tanggapan resmi terhadap epidemi di kota dan wilayah kepresidenan Bombay (1818-1821) pada awalnya bersifat perbaikan, termasuk merekrut asisten medis pribumi untuk memberikan pengobatan. Tindakan seperti itu diperhitungkan untuk menumbuhkan citra baik pemerintah kolonial di kalangan penduduk setempat. Meskipun ada perbedaan pendapat nosologis dan etiologis, anggota Dewan Medis Bombay menggolongkan kolera sebagai penyakit sosial. Berbeda dengan epidemi kolera pada paruh kedua abad ke-19, epidemi kolera yang pertama pada masa kepresidenan Bombay tidak banyak memperburuk antagonisme terhadap pemerintah kolonial karena dua alasan. Pertama, kekuatan Inggris di India masih dalam tahap pembentukan. Kedua, baik di India maupun Inggris, kolera dikaitkan dengan gangguan humor tubuh. Sebaliknya, epidemi ini memberikan stimulus terhadap perselisihan antar masyarakat.

Mridula Ramanna, <i>Bombay Presidency, 1850–1920: Disease, Sanitation and Public Health Personalities</i>
Vivek Neelakantan
2024· Social History of Medicinedoi:10.1093/shm/hkae048

Journal Article Mridula Ramanna, Bombay Presidency, 1850–1920: Disease, Sanitation and Public Health Personalities Get access Mridula Ramanna, Bombay Presidency, 1850–1920: Disease, Sanitation and Public Health Personalities, New Delhi: Primus Books, 2024. Pp. 343. INR 1400. Hbk. ISBN 9789358522051. Vivek Neelakantan Vivek Neelakantan Independent Southeast Asian Medical Historian, 2023 Brocher Foundation Fellow, Hermance, Switzerland vivekneelakantanster@gmail.com Search for other works by this author on: Oxford Academic PubMed Google Scholar Social History of Medicine, hkae048, https://doi.org/10.1093/shm/hkae048 Published: 16 July 2024